Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV-MPL vs Engerix-B Immunogenicity in Healthy Adults
NCT00698906Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 1997
- Primary completion
- Feb 1998
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Jun 1997; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00698906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698906.